Smoking determines the 10-year (2004-2014) prognosis in patients with Acute Coronary Syndrome: The GREECS observational study

Tobacco Induced Diseases

Volumn 13, Issue 1, 2015, Pages

  Notara, Venetia ^a   Panagiotakos, Demosthenes B ^a   Kouroupi, Semina ^a   Stergiouli, Ifigenia ^g   Kogias, Yannis ^c   Stravopodis, Petros ^d   Papanagnou, George ^e   Zombolos, Spyros ^f   Mantas, Yannis ^g   Antonoulas, Antonis ^e   Pitsavos, Christos ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c General Hospital of Karditsa   (Greece)

^d Cardiology Clinic   (Greece)

^e General Hospital of Lamia   (Greece)

^f Kalamata General Hospital   (Greece)

^g General Hospital of Chalkida   (Greece)

Author keywords

Acute Coronary Syndrome; Cardiovascular risk factors; Disease clinical burden; Lifestyle habits; Smoking

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PASSIVE SMOKING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RISK REDUCTION; SMOKING; SMOKING CESSATION; SMOKING HABIT; SURVIVAL RATE;

EID: 84948405673     PISSN: None     EISSN: 16179625     Source Type: Journal    
DOI: 10.1186/s12971-015-0063-6     Document Type: Article

References (47)

1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes 3rd J. Factors of risk in the development of coronary heart disease - six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50.
2. Keys A, Menotti A, Aravanis C, Blackburn H, Djordevic BS, Buzina R, et al. The seven countries study: 2,289 deaths in 15 years. Prev Med. 1984;13(2):141-54.
3. Raupach T, Schafer K, Konstantinides S, Andreas S. Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J. 2006;27(4):386-92. doi: 10.1093/eurheartj/ehi601.
4. Panagiotakos DB, Rallidis LS, Pitsavos C, Stefanadis C, Kremastinos D. Cigarette smoking and myocardial infarction in young men and women: a case-control study. Int J Cardiol. 2007;116(3):371-5. doi: 10.1016/j.ijcard.2006.04.051.
5. Pyrgakis VN. Smoking and cardiovascular disease. Hellenic J Cardiol. 2009;50(3):231-4.
6. Berndt N, Bolman C, Mudde A, Verheugt F, de Vries H, Lechner L. Risk groups and predictors of short-term abstinence from smoking in patients with coronary heart disease. Heart Lung. 2012;41(4):332-43. doi: 10.1016/j.hrtlng.2012.03.001.
7. Griffo R, Ambrosetti M, Tramarin R, Fattirolli F, Temporelli PL, Vestri AR, et al. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey. Int J Cardiol. 2013;167(4):1390-5. doi: 10.1016/j.ijcard.2012.04.069.
8. Scholte op Reimer W, de Swart E, De Bacquer D, Pyorala K, Keil U, Heidrich J, et al. Smoking behaviour in European patients with established coronary heart disease. Eur Heart J. 2006;27(1):35-41. doi: 10.1093/eurheartj/ehi497.
9. Denollet J, Pedersen SS. Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol. 2009;53(11):947-9. doi: 10.1016/j.jacc.2008.12.006.
10. Wiggers LC, Oort FJ, Dijkstra A, de Haes JC, Legemate DA, Smets EM. Cognitive changes in cardiovascular patients following a tailored behavioral smoking cessation intervention. Prev Med. 2005;40(6):812-21. doi: 10.1016/j.ypmed.2004.09.028.
11. Lett HS, Blumenthal JA, Babyak MA, Catellier DJ, Carney RM, Berkman LF, et al. Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med. 2009;16(3):248-58. doi: 10.1007/s12529-009-9040-x.
12. Pitsavos C, Panagiotakos DB, Chrysohoou C, Skoumas J, Tzioumis K, Stefanadis C, et al. Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study. Tob Control. 2002;11(3):220-5.
13. Munteanu I, Mihaltan FD. Second-hand Smoking and CV Risk. Curr Treat Options Cardiovasc Med. 2014;16(12):348. doi: 10.1007/s11936-014-0348-8.
14. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111(20):2684-98. doi: 10.1161/CIRCULATIONAHA.104.492215.
15. Dunbar A, Gotsis W, Frishman W. Second-hand tobacco smoke and cardiovascular disease risk: an epidemiological review. Cardiol Rev. 2013;21(2):94-100. doi: 10.1097/CRD.0b013e31827362e4.
16. Borland R, Yong HH, Cummings KM, Hyland A, Anderson S, Fong GT. Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15 Suppl 3:iii42-50. doi: 10.1136/tc.2005.012492.
17. Pitsavos C, Panagiotakos DB, Antonoulas A, Zombolos S, Kogias Y, Mantas Y, et al. Epidemiology of acute coronary syndromes in a Mediterranean country; aims, design and baseline characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health. 2005;5:23. doi: 10.1186/1471-2458-5-23.
18. Braunwald E. Heart Disease. 5th ed. London, UK: W.B. Saunders Company; 1997.
19. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21(18):1502-13. doi:10.1053/euhj.2000.2305.
20. State-specific secondhand smoke exposure and current cigarette smoking among adults - United States 2008. MMWR Morb Mortal Wkly Rep. 2009;58(44):1232-5. http://dhds.cdc.gov/guides/healthtopics/indicator?I=smokingstatus. Last accessed March 7, 2015
21. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med. 2007;44(4):335-40. doi: 10.1016/j.ypmed.2006.12.009.
22. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273(5):402-7.
23. Ariizumi H, Schirle T. Are recessions really good for your health? Evidence from Canada. Soc Sci Med. 2012;74(8):1224-31. doi: 10.1016/j.socscimed.2011.12.038.
24. Shaw BA, Agahi N, Krause N. Are changes in financial strain associated with changes in alcohol use and smoking among older adults? J Stud Alcohol Drugs. 2011;72(6):917-25.
25. Giskes K, Kunst AE, Benach J, Borrell C, Costa G, Dahl E et al. Trends in smoking behaviour between 1985 and 2000 in nine European countries by education. J Epidemiol Community Health. 2005;59(5):395-401. doi:59/5/395 [pii]10.1136/jech.2004.025684.
26. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292.
27. Violaris AG, Thury A, Regar E, Melkert R, Serruys PW. Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart. 2000;84(3):299-306.
28. Pollock JS, Hollenbeck RD, Wang L, Janz DR, Rice TW, McPherson JA. A history of smoking is associated with improved survival in patients treated with mild therapeutic hypothermia following cardiac arrest. Resuscitation. 2014;85(1):99-103. doi: 10.1016/j.resuscitation.2013.08.275.
29. Kirtane AJ, Kelly CR. Clearing the air on the "smoker's paradox". J Am Coll Cardiol. 2015;65(11):1116-8. doi: 10.1016/j.jacc.2015.01.012.
30. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273-83. doi: 10.1001/jama.2012.339.
31. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86-97. doi: 10.1001/jama.290.1.86 290/1/86.
32. Thyrian JR, Panagiotakos DB, Polychronopoulos E, West R, Zatonski W, John U. The relationship between smokers' motivation to quit and intensity of tobacco control at the population level: a comparison of five European countries. BMC Public Health. 2008;8:2. doi: 10.1186/1471-2458-8-2.
33. Tang L, Patao C, Chuang J, Wong ND. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). Am J Cardiol. 2013;112(8):1126-32. doi: 10.1016/j.amjcard.2013.05.064.
34. Japuntich SJ, Eilers MA, Shenhav S, Park ER, Winickoff JP, Benowitz NL, et al. Secondhand tobacco smoke exposure among hospitalized nonsmokers with coronary heart disease. JAMA Intern Med. 2015;175(1):133-6. doi: 10.1001/jamainternmed.2014.5476.
35. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224-60. doi: 10.1016/S0140-6736(12)61766-8.
36. CDC Fact Sheet Tobacco-Related Mortality. 2014. Available at: http://www.cdc.gov/tobacco/data-statistics/fact-sheets/health-effects/tobacco-related-mortality/ Lasta assessed March 17, 2015.
37. Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Masoura C, Toutouzas P, et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med. 2004;116(3):145-50.
38. Vardavas CI, Panagiotakos DB. The causal relationship between passive smoking and inflammation on the development of cardiovascular disease: a review of the evidence. Inflamm Allergy Drug Targets. 2009;8(5):328-33.
39. Verheugt FW. Passive smoking and the risk of coronary heart disease. Ned Tijdschr Geneeskd. 2004;148(14):645-7.
40. Shiue I. Effect of smoking ban at home on adult cardiovascular health: Scottish Health Survey, 2012. Int J Cardiol. 2014;176(1):268-9. doi: 10.1016/j.ijcard.2014.06.097.
41. Winickoff JP, Friebely J, Tanski SE, Sherrod C, Matt GE, Hovell MF, et al. Beliefs about the health effects of "thirdhand" smoke and home smoking bans. Pediatrics. 2009;123(1):e74-9. doi: 10.1542/peds.2008-2184.
42. Huttunen-Lenz M, Song F, Poland F. Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? Meta-analysis of interventions. Br J Health Psychol. 2010;15:749-77.
43. Eisenberg MJ, Blum LM, Filion KB, Rinfret S, Pilote L, Paradis G, et al. The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials. Can J Cardiol. 2010;26:73-9.
44. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121:221-9.
45. Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. Drug Saf. 2008;31:1017-26.
46. Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84(7):1086-93.
47. Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D. Assessment of validity of self-reported smoking status. Health Rep. 2012;23(1):47-53.